H.R. 980 (108th): Access to Innovation for Medicare Patients Act of 2003

Introduced:
Feb 27, 2003 (108th Congress, 2003–2004)
Status:
Died (Referred to Committee)
Sponsor
Jennifer Dunn
Representative for Washington's 8th congressional district
Party
Republican
Text
Read Text »
Last Updated
Feb 27, 2003
Length
2 pages
Related Bills
H.R. 1089 (107th) was a previous version of this bill.

Referred to Committee
Last Action: Mar 19, 2001

 
Status

This bill was introduced on February 27, 2003, in a previous session of Congress, but was not enacted.

Progress
Introduced Feb 27, 2003
Referred to Committee Feb 27, 2003
 
Full Title

To amend title XVIII of the Social Security Act to expand Medicare coverage of certain self-injected biologicals.

Summary

No summaries available.

Cosponsors
62 cosponsors (37D, 25R) (show)
Committees

House Energy and Commerce

House Ways and Means

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


2/27/2003--Introduced.
Access to Innovation for Medicare Patients Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or a biological that otherwise cannot be self-administered.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 980 (108th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus